Regulatory Information
ZYFAS PHARMA PTE LTD
ZYFAS PHARMA PTE LTD
Therapeutic
Prescription Only
Formulation Information
CAPSULE
**DOSAGE AND ADMINISTRATION** Adults: Hypertension one capsule daily. Adults: Angina one capsule daily. If necessary, additional Nifedipine or prophylactic nitrate therapy.
ORAL
Medical Information
**INDICATIONS** All grades of Hypertension and Angina.
**CONTRAINDICATIONS** NIFETEX-TR should be used with caution in patients with impaired renal function. Since Nifedipine may cause a decrease in peripheral resistance, careful monitoring of blood pressure during initial stages of therapy is suggested. Care has to be taken in patients with conduction defects or poor cardiac reserve. Care should be taken when co-administered with class one antidysrhythmic agents and with anaesthetics, caution in patients with chronic obstructive airways disease and asthma. Caution should be taken in transferring patients from clonidine. Diabetes patients may require adjustment of their drug therapy.
C08CA55
nifedipine, combinations
Manufacturer Information
ZYFAS PHARMA PTE. LTD.
WINTAC LIMITED
STERIL-GENE LIFE SCIENCES (P) LIMITED
Active Ingredients
Documents
Package Inserts
Nifetex-TR capsules PI.pdf
Approved: August 24, 2021